Vistin Pharma ASAOSL:VISTN -0.97%80 Dividend Yield % is 4.90% as of Jul. 06, 2026, which is 8% above its 10-year median of 4.53. GuruFocus rates OSL:VISTN with a GF Score™ of 80/100 and a GF Value™ of kr25.61 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 518 Drug Manufacturers companies, Vistin Pharma ASA ranks better than 87.45% on this metric.
As of today (2026-07-06), the Trailing Annual Dividend Yield of Vistin Pharma ASA is 4.90%.
Warning Sign:
Vistin Pharma ASA stock Dividend Yield % is close to 1-year low.
The historical rank and industry rank for Vistin Pharma ASA's Dividend Yield % or its related term are showing as below:
OSL:VISTN'
s Dividend Yield % Range Over the Past 10 Years
Min: 2.08 Med: 4.53 Max: 9.22
Current: 4.9
During the past 13 years, the highest Dividend Yield of Vistin Pharma ASA was 9.22%. The lowest was 2.08%. And the median was 4.53%.
OSL:VISTN's Dividend Yield % is ranked better than 87.45% of 518
companies
in the Drug Manufacturers industry
Industry Median: 1.92
vs OSL:VISTN: 4.90
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Vistin Pharma ASA is 0.73, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of Vistin Pharma ASA was 3.06. The lowest was 0.65. And the median was 1.06.
During the past 12 months, Vistin Pharma ASA's average Dividends Per Share Growth Rate was 25.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Vistin Pharma ASA was 51.80% per year. The lowest was 0.70% per year. And the median was 26.25% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Vistin Pharma ASA Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Vistin Pharma ASA's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:VISTN vs ZTS, UTHR, VTRS: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vistin Pharma ASA Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Vistin Pharma ASA's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Vistin Pharma ASA Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
NOK 1.000000
2026-05-22
2026-05-26
2026-05-29
Cash Dividend
semi-annually
NOK:NOK 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Vistin Pharma ASA's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vistin Pharma ASA (OSL:VISTN) has a Dividend Yield % of 4.90% as of Jul. 06, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Vistin Pharma ASA and its competitors. This is near median its historical median of 4.53. Over the past decade, Vistin Pharma ASA's Dividend Yield % has ranged from 2.08 to 9.22. According to the industry distribution chart, Vistin Pharma ASA ranks #65 out of 518 companies in the Drug Manufacturers industry, placing it in the top 12.5%.
Is Vistin Pharma ASA's Dividend Yield % too high?
Vistin Pharma ASA's current Dividend Yield % of 4.90% is near median its 10-year median of 4.53. Over the past 10 years, this metric has ranged from a low of 2.08 to a high of 9.22. The Drug Manufacturers industry median Dividend Yield % is 1.92. Vistin Pharma ASA's value of 4.90% is 155.2% above this industry median. Based on the distribution chart, Vistin Pharma ASA ranks #65 out of 518 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vistin Pharma ASA has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vistin Pharma ASA's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vistin Pharma ASA ranks #65 out of 518 companies for Dividend Yield %. This places Vistin Pharma ASA in the top 13% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.92. Vistin Pharma ASA's value of 4.90% is 155.2% above this benchmark. Historically, Vistin Pharma ASA's own Dividend Yield % has ranged from 2.08 to 9.22 over the past decade. While the company's 10-year median is 4.53 vs. the industry median of 1.92, Vistin Pharma ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.92, based on 518 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vistin Pharma ASA's current Dividend Yield % of 4.90% is 155.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Vistin Pharma ASA and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vistin Pharma ASA's current Dividend Yield % is 4.90%, which is near median its own 10-year median of 4.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vistin Pharma ASA stock overvalued right now?
Based on GuruFocus' analysis, Vistin Pharma ASA (OSL:VISTN) is currently considered Modestly Undervalued. The stock's GF Value™ is kr25.61, compared to a current price of kr20.40 — trading 20.3% below its estimated fair value. The current Dividend Yield % is 4.90%, which is near median its 10-year median of 4.53 and 155.2% above the Drug Manufacturers industry median of 1.92. Vistin Pharma ASA's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Vistin Pharma ASA (OSL:VISTN), the current Dividend Yield % is 4.90% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vistin Pharma ASA (OSL:VISTN) Overvalued in 2026?
Based on GuruFocus' analysis, Vistin Pharma ASA stock appears to be undervalued.
The current stock price of kr20.40 is trading 20.3% below its estimated GF Value™ of kr25.61.
GuruFocus considers Vistin Pharma ASA to be Modestly Undervalued.
Key valuation signals for OSL:VISTN:
Dividend Yield %: 4.90% (near median its 10-year median of 4.53)
GF Value™: kr25.61 vs. price of kr20.40 (20.3% below fair value)
Industry Position: 155.2% above the Drug Manufacturers median (#65 of 518)
No single metric tells the full story. See the OSL:VISTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
80GF Score
Get the complete analysis for OSL:VISTN
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:VISTN has been successfully added to your 
